Salim Hayek, MD
Pain Medicine · Cleveland, OHNPI 1770501272
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Biotronik Inc. at 28.4% of the total. Reporting peaked in 2019 at $15,637 and has fallen 83.9% since, to $2,525 in 2025. Among pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $146.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$10K
- Abbott$7K
- Boston Scientific$6K
- Nevro Corp.$2K
- Vertiflex, Inc.$2K
- B. Braun Miethke GmbH & Co. KG$1K
- plus $5K from 26 others
Across 38 payments — averaging $7294.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stimwave Technologies Incorporated$153K
- MML US, Inc.$79K
- Vertex$39K
- Scilex Pharmaceuticals Inc.$5K
- Saluda Medical Americas, Inc.$319
What the payments were for
- Consulting fees$13,78341%
- Travel & lodging$5,31616%
- Food & beverage$14,69843%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 17 | $9,621 |
| Abbott | 19 | $7,235 |
| Boston Scientific | 60 | $6,231 |
| Nevro Corp. | 17 | $2,495 |
| Vertiflex, Inc. | 9 | $1,852 |
| B. Braun Miethke GmbH & Co. KG | 1 | $1,320 |
| Saluda Medical Americas, Inc. | 9 | $856 |
| Globus Medical | 7 | $834 |
| Vertos Medical, Inc. | 4 | $421 |
| Averitas Pharma Inc. | 19 | $409 |
| MML US, Inc. | 2 | $376 |
| Curonix LLC | 3 | $328 |
| SPR Therapeutics, Inc | 6 | $310 |
| Stimwave Technologies Incorporated | 2 | $275 |
| Azurity Pharmaceuticals, Inc. | 12 | $219 |
| Arbor Pharmaceuticals, Inc. | 13 | $184 |
| Stryker | 1 | $146 |
| Medtronic | 2 | $139 |
| Biodelivery Sciences International, Inc. | 1 | $120 |
| GRT US Holding, Inc. | 6 | $77 |
| Tersera Therapeutics LLC | 2 | $61 |
| Relievant Medsystems, Inc. | 5 | $52 |
| Nalu Medical, Inc. | 1 | $43 |
| Almatica Pharma LLC | 3 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $30 |
| Novartis | 1 | $27 |
| Amgen | 1 | $26 |
| Lilly USA, LLC | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$6,292
- WaveWriter Alpha Prime 16$2,504
- Superion ISS$1,673
- Senza Spinal Cord Stimulation System$1,426
- PRODUCT UNDER DEVELOPMENT - NO BRAND NAME$1,320
- SPECTRA WAVEWRITER$1,174
- GENERAL PAIN MANAGEMENT$1,103
- Senza$889
- mild Device Kit$509
- Evoke SCS$438
- ReActiv8$376
- Proclaim Family of SCS IPGs$369
- WAVEWRITER ALPHA$347
- Omnia$345
- Evoke$277
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$255
- SPRINT PNS System$246
- SUPERION$146
- StimQ Receiver Stimulator Kit Channel A US w Receiver$141
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$141
How this compares
$33,833 in reported general payments places this provider in the 95th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 1,197 | $15,927 |
| HorizantGabapentin Enacarbil | 14 | $13,660 |
| Topiramate | 347 | $5,511 |
| Pregabalin | 125 | $3,745 |
| Duloxetine Hcl | 183 | $3,359 |
| Lidocaine | 16 | $2,941 |
| Amitriptyline Hcl | 245 | $2,548 |
| Oxycodone Hcl | 209 | $2,096 |
| Tizanidine Hcl | 92 | $1,091 |
| Baclofen | 101 | $1,055 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 65 | $999 |
| Desipramine Hcl | 35 | $964 |
| Tramadol Hcl | 121 | $845 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $390 |
| Hydromorphone Hcl | 23 | $225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Arbor Pharmaceuticals, Inc.Horizant | $184 | $13,66014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 245 pain medicine providers in Ohio.
Other pain medicine in Cleveland
- Nagy MekhailCleveland$511K
- Robert BolashCleveland$154K
- Aman UpadhyayCleveland$40K
- Trishul KapoorCleveland$33K
- Edward CovingtonCleveland$25K
- Jianguo ChengCleveland$23K
- Kush GoyalCleveland$22K
- Jacob EzellCleveland$12K
- Jijun XuCleveland$10K
- Riad LahamCleveland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.